Tech Company Financing Transactions

D3 Bio Funding Round

D3 Bio closed a $40 million investment round on 4/8/2024. Investors included Medicxi Ventures.

Transaction Overview

Company Name
Announced On
4/8/2024
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to accelerate the development of its pipeline of oncology compounds.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
88 MeiLiang Road; MaShan Street; BinHu District 324
Wuxi, JiangSu, 214000
China
Phone
Undisclosed
Email Address
Overview
D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we start from pinpointing the greatest unmet patient and market needs -- where existing standard-of-care approaches yield unsatisfactory clinical outcomes.
Profile
D3 Bio LinkedIn Company Profile
Social Media
D3 Bio Company Twitter Account
Company News
D3 Bio News
Facebook
D3 Bio on Facebook
YouTube
D3 Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
George Chen
  George Chen LinkedIn Profile  George Chen Twitter Account  George Chen News  George Chen on Facebook
Chief Financial Officer
John Jin
  John Jin LinkedIn Profile  John Jin Twitter Account  John Jin News  John Jin on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/7/2024: Astek Diagnostics venture capital transaction
Next: 4/8/2024: Ubit venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary